The latest news on FDA
Half of batches tested positive, third of popular sweetened products showed traces
Stem cell promise new disease treatments but haven't yet delivered.
First stem cell trial in humans may be followed by end on federal ban.
Might improve function in paralyzed patients, experts say
Today's selection of timely reports.
Popular topical anesthetics can cause severe reactions when used improperly, agency says
Congenital fibrinogen deficiency can cause uncontrolled bleeding
Expected in pharmacies by March
Consumer labeling not required for foods from these animals, agency says
An infection commonly acquired in hospitals